Alpha-2 adrenergic receptor polymorphisms
The present invention includes polymorphisms in nucleic acids encoding the alpha-2B, alpha-2A, and alpha-2C adrenergic receptor and expressed alpha-2B, alpha-2A and alpha-2C adrenergic receptor molecule. The invention also pertains to methods and molecules for detecting such polymorphisms. The invention further pertains to the use of such molecules and methods in the diagnosis, prognosis, and treatment of diseases such as cardiovascular and central nervous system disease.
1. An isolated polynucleotide encoding an alpha-2C adrenergic receptor molecule or fragment or complement of the polynucleotide, having a polymorphic site comprising ggggcggctgag; SEQ ID NO: 43 at nucleotide positions 964 to 975.
2. An isolated polynucleotide according to claim 1 , wherein the polynucleotide comprises ggggcggctgag; SEQ ID NO: 43 at nucleotide positions 964 to 975 with up to 20 additional nucleotides on either the 5″ or 3″ end or both.
3. An isolated oligonucleotide that specifically hybridizes to a region of a polynucleotide encoding an alpha-2C adrenergic receptor molecule or fragment of the polynucleotide, wherein the region comprises at least one polymorphic site comprising ggggcggctgag; SEQ ID NO: 43 at nucleotide positions 964 to 975 wherein the oligonucleotide permits identification of one polymorphic site comprising ggggcggctgag; SEQ ID NO: 43 at nucleotide positions 964 to 975.
4. An isolated oligonucleotide according to claim 3 , wherein the oligonucleotide is a primer that specifically hybridizes to a region immediately adjacent to nucleotide positions 964 to 975.